Apolipoprotein E polymorphism and renal disease.

doi:10.1046/j.1523-1755.1999.07107.x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Apolipoprotein E polymorphism and renal disease.

Kidney international. Supplement - 1 Jul 1999

Oda H, Yorioka N, Ueda C, Kushihata S, Yamakido M

Abstract excerpt

BACKGROUND: Lipid abnormalities are frequently found in end-stage renal disease (ESRD), and abnormal lipid metabolism may contribute to the progression of renal disease. Previous investigators have reported that apolipoprotein E (apoE) has an important role in lipoprotein metabolism and that the process of lipoprotein catabolism varies according to the apoE phenotype. In addition, the relative frequency of the...

Topics

Alleles
Apolipoprotein E2
Apolipoproteins E
Gene Frequency
Glomerulonephritis
Humans
Kidney Diseases
Kidney Failure, Chronic
Lipids
Phenotype
Polymorphism, Genetic

Source

Open in PubMed

Identifiers

PMID: 10412731
DOI: 10.1046/j.1523-1755.1999.07107.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics